Advertisement
In a EuroNet Pediatric Hodgkin Lymphoma Group guideline

Recommendations Issued for R/R Pediatric Hodgkin Lymphoma

0
Recommendations developed for salvage therapy for pediatric patients with first relapse/refractory cHL
For middle-aged and older adults at high cardiovascular risk without diabetes

Intensive BP Control Has Positive Impact on Residual Life Span

0
Mean survival benefits varied from six months to three years for intensive versus standard BP control
Public opinion about the Affordable Care Act remains divided 10 years after its passage

Influence of Politics Has Not Waned in Opinions About ACA

0
Partisan divisions in favorable opinion of the ACA have gotten larger rather than smaller over time
The University of Nebraska Medical Center has launched the first clinical trial in the United States of a possible treatment for the new coronavirus.

First U.S. Trial of Possible Coronavirus Treatment Begins

0
University of Nebraska Medical Center is treating 14 people who were evacuated from cruise ship in Japan
For patients with untreated stage II or III triple-negative breast cancer

Adding Pembrolizumab May Up Response in Triple-Negative Breast Cancer

0
Pathological complete response rate higher with pembrolizumab plus neoadjuvant chemotherapy
Long-term antidepressant use increases the risk for type 2 diabetes onset in a time- and dose-dependent manner

Long-Term Antidepressant Use Appears to Raise Risk for T2DM

0
Study suggests glucose tolerance improves with antidepressant discontinuation or dose reduction
For adults with exacerbation of chronic obstructive pulmonary disease

Antibiotics, Corticosteroids Beneficial in COPD Exacerbations

0
Independent of exacerbation severity, antibiotics tied to increased resolution, less treatment failure
Medication treatment with methadone and buprenorphine is associated with a significantly lower risk for overdose death for people with opioid use disorder compared with nonmedication treatment

Medication Treatment May Lower Risk for Opioid Overdose Death

0
But protective effect during care does not last after discontinuation of treatment for opioid use disorder
Intensive behavioral therapy produces clinically meaningful weight loss in a primary care setting

Liraglutide Enhances Weight Loss With Intensive Behavioral Therapy

0
Clinically meaningful weight loss seen over 56 weeks with IBT and 3.0 mg liraglutide

American Stroke Association, Feb. 19-21

0
The American Heart Association/American Stroke Association International Stroke Conference The annual International Stroke Conference of the American Heart Association/American Stroke Association was held...